CD69 and myeloid sarcoma: Despite the variable background of the brain donors, consisting of patients with Alzheimer’s disease, Parkinson’s disease, dementia, depression, and MS, as well as controls with no known neurological disorders, brain CD69+ memory T cells displayed a consistent transcriptional profile that clearly differed from circulating TEM(RA) cells.